{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:02:20Z","timestamp":1791597740501,"version":"4.3.4"},"reference-count":108,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EN 179\/13-1"],"award-info":[{"award-number":["EN 179\/13-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.medj.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T19:32:37Z","timestamp":1634067157000},"page":"1171-1193.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin\u2019s lymphoma and facilitates ultrasensitive residual disease detection"],"prefix":"10.1016","volume":"2","author":[{"given":"Sophia","family":"Sobesky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laman","family":"Mammadova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melita","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther E.E.","family":"Drees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Mattlener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Altm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Br\u00f6ckelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Kreissl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Sasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland T.","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9729-4030","authenticated-orcid":false,"given":"Sarah","family":"Reinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gerhard-Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaretha G.M.","family":"Roemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"N\u00fcrnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Hagenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1074-5922","authenticated-orcid":false,"given":"Jos\u00e9e M.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk Michiel","family":"Pegtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Borchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"von Tresckow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6662-6864","authenticated-orcid":false,"given":"Sven","family":"Borchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2021.09.002_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/CCO.0000000000000314","article-title":"Current developments in the treatment of early-stage classical Hodgkin lymphoma","volume":"28","author":"Borchmann","year":"2016","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib2","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"K\u00fcppers","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.medj.2021.09.002_bib3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S1470-2045(16)30093-6","article-title":"Cancer-related fatigue in patients with and survivors of Hodgkin\u2019s lymphoma: a longitudinal study of the German Hodgkin Study Group","volume":"17","author":"Kreissl","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib4","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2013-07-512657","article-title":"Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group","volume":"123","author":"Eichenauer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41375-018-0240-8","article-title":"Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG)","volume":"33","author":"Borchmann","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.medj.2021.09.002_bib6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/annonc\/mdz168","article-title":"Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials","volume":"30","author":"Borchmann","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2012.44.3721","article-title":"Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials","volume":"31","author":"Behringer","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrclinonc.2012.91","article-title":"State of the art in the treatment of Hodgkin lymphoma","volume":"9","author":"Borchmann","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib9","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2021.09.002_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/bjh.15658","article-title":"The translational science of hodgkin lymphoma","volume":"184","author":"Cirillo","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.medj.2021.09.002_bib11","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/CCO.0000000000000396","article-title":"The genetics of Hodgkin lymphoma: an overview and clinical implications","volume":"29","author":"Borchmann","year":"2017","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib14","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.medj.2021.09.002_bib15","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","article-title":"Results of a trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma","volume":"372","author":"Radford","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2021.09.002_bib16","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2013.51.9298","article-title":"Omitting radiotherapy in early positron emission tomography-negative stage I\/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"32","author":"Raemaekers","year":"2014","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib17","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.19.00964","article-title":"Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: Final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group","volume":"37","author":"Fuchs","year":"2019","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib18","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin\u2019s Lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2021.09.002_bib19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1182\/blood.2019000719","article-title":"Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III\/IV Hodgkin lymphoma","volume":"134","author":"Stephens","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib20","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","article-title":"PET-guided treatment in patients with advanced-stage Hodgkin\u2019s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group","volume":"390","author":"Borchmann","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2021.09.002_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.2017.75.2543","article-title":"Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography\/computed tomography scan after two abvd cycles: Long-term results of the GITIL\/FIL HD 0607 trial","volume":"36","author":"Gallamini","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(20)30601-X","article-title":"PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Borchmann","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2021.09.002_bib24","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2352-3026(14)00039-8","article-title":"Non-invasive detection of genomic imbalances in Hodgkin\/Reed-Sternberg cells in early and advanced stage Hodgkin\u2019s lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study","volume":"2","author":"Vandenberghe","year":"2015","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.medj.2021.09.002_bib25","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41375-019-0541-6","article-title":"Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma","volume":"34","author":"Desch","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.medj.2021.09.002_bib27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/annonc\/mdp006","article-title":"Cell-free circulating DNA in Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas","volume":"20","author":"Hohaus","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3324\/haematol.2019.237719","article-title":"Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study","volume":"106","author":"Camus","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.medj.2021.09.002_bib29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nbt.3520","article-title":"Integrated digital error suppression for improved detection of circulating tumor DNA","volume":"34","author":"Newman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.medj.2021.09.002_bib30","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","article-title":"Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma","volume":"36","author":"Kurtz","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12859-018-2428-3","article-title":"TNER: a novel background error suppression method for mutation detection in circulating tumor DNA","volume":"19","author":"Deng","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.medj.2021.09.002_bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41587-019-0074-6","article-title":"An open resource for accurately benchmarking small variant and reference calls","volume":"37","author":"Zook","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.medj.2021.09.002_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41587-019-0054-x","article-title":"Best practices for benchmarking germline small-variant calls in human genomes","volume":"37","author":"Krusche","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"Suppl 1","key":"10.1016\/j.medj.2021.09.002_bib34","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.medj.2021.09.002_bib35","article-title":"Exhaustive circulating tumor DNA sequencing reveals genomic landscape of Hodgkin lymphoma and facilitates ultrasensitive residual disease detection","author":"Sobesky","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.medj.2021.09.002_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.medj.2021.09.002_bib37","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.medj.2021.09.002_bib39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.medj.2021.09.002_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/humu.22963","article-title":"mutation3D: Cancer Gene Prediction Through Atomic Clustering of Coding Variants in the Structural Proteome","volume":"37","author":"Meyer","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.medj.2021.09.002_bib41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/onc.2013.571","article-title":"Oncogenic Y641 mutations in EZH2 prevent Jak2\/\u03b2-TrCP-mediated degradation","volume":"34","author":"Sahasrabuddhe","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.medj.2021.09.002_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.medj.2021.09.002_bib43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.medj.2021.09.002_bib44","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1084\/jem.20180639","article-title":"Gain-of-function IKBKB mutation causes human combined immune deficiency","volume":"215","author":"Cardinez","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.medj.2021.09.002_bib45","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1182\/blood-2011-04-350579","article-title":"IRF4 mutations in chronic lymphocytic leukemia","volume":"118","author":"Havelange","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib46","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1074\/jbc.RA117.000164","article-title":"An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia","volume":"293","author":"Cherian","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.medj.2021.09.002_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2141.2010.08497.x","article-title":"IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion","volume":"152","author":"Aldinucci","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.medj.2021.09.002_bib49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2021.09.002_bib50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7150\/jca.12067","article-title":"Loss of IRF8 inhibits the growth of diffuse large B-cell lymphoma","volume":"6","author":"Xu","year":"2015","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.medj.2021.09.002_bib51","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib52","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/leu.2009.103","article-title":"STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line","volume":"23","author":"Baus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.medj.2021.09.002_bib53","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3324\/haematol.2016.145102","article-title":"Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma","volume":"101","author":"Camus","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.medj.2021.09.002_bib54","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1158\/2159-8290.CD-19-0298","article-title":"Altered nuclear export signal recognition as a driver of oncogenesis","volume":"9","author":"Taylor","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2021.09.002_bib55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13059-016-1114-x","article-title":"A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence","volume":"17","author":"Canisius","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.medj.2021.09.002_bib56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.medj.2021.09.002_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","article-title":"DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution","volume":"17","author":"Rosenthal","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.medj.2021.09.002_bib58","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2019.02.012","article-title":"Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis","volume":"176","author":"Petljak","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.medj.2021.09.002_bib59","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.4049\/jimmunol.1202547","article-title":"Multiple transcription factor binding sites predict AID targeting in non-Ig genes","volume":"190","author":"Duke","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.medj.2021.09.002_bib61","doi-asserted-by":"crossref","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.medj.2021.09.002_bib62","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.medj.2021.09.002_bib63","article-title":"An atlas of bacterial and viral associations in cancer","author":"Borchmann","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.medj.2021.09.002_bib64","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/gb-2014-15-3-r46","article-title":"Kraken: ultrafast metagenomic sequence classification using exact alignments","volume":"15","author":"Wood","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.medj.2021.09.002_bib65","series-title":"Hodgkin Lymphoma: A Comprehensive Overview","first-page":"25","article-title":"The Role of Viruses in the Genesis of Hodgkin Lymphoma","author":"Jarrett","year":"2020"},{"key":"10.1016\/j.medj.2021.09.002_bib66","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/oxfordjournals.annonc.a058187","article-title":"Association of Epstein-Barr virus genome with mixed cellularity and cellular phase nodular sclerosis Hodgkin\u2019s disease subtypes","volume":"3","author":"Boiocchi","year":"1992","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/annonc\/7.suppl_4.S5","article-title":"Epidemiology of EBV and Hodgkin\u2019s lymphoma","volume":"7","author":"Jarrett","year":"1995","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib68","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1158\/1078-0432.CCR-19-4137","article-title":"A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models","volume":"26","author":"Wei","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.medj.2021.09.002_bib69","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/JCM.44.1.160-165.2006","article-title":"Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases","volume":"44","author":"Han","year":"2006","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.medj.2021.09.002_bib70","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/s41467-020-16375-6","article-title":"Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"11","author":"Thurner","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2021.09.002_bib71","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.2019002067","article-title":"Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade","volume":"134","author":"Chapuy","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib72","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2020007507","article-title":"Mutational landscape of gray zone lymphoma","volume":"137","author":"Sarkozy","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib73","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin\u2019s lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.medj.2021.09.002_bib74","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.13441","article-title":"Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis","volume":"170","author":"Adams","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.medj.2021.09.002_bib75","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Lord","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.medj.2021.09.002_bib76","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2021.09.002_bib77","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nmeth.2883","article-title":"PyClone: statistical inference of clonal population structure in cancer","volume":"11","author":"Roth","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.medj.2021.09.002_bib79","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ccell.2020.04.004","article-title":"Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response","volume":"37","author":"B\u00e9guelin","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medj.2021.09.002_bib80","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00000478-198603000-00005","article-title":"Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases","volume":"10","author":"Perrone","year":"1986","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.medj.2021.09.002_bib81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajh.23361","article-title":"Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma","volume":"88","author":"Sauer","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.medj.2021.09.002_bib82","doi-asserted-by":"crossref","first-page":"e89631","DOI":"10.1172\/jci.insight.89631","article-title":"Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients","volume":"1","author":"van Eijndhoven","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.medj.2021.09.002_bib83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bjh.16514","article-title":"Interim thymus and activation regulated chemokine versus interim 18 F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation","volume":"190","author":"Plattel","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.medj.2021.09.002_bib84","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.medj.2021.09.002_bib85","article-title":"Selecting Short DNA Fragments In Plasma Improves Detection Of Circulating Tumour DNA","author":"Mouliere","year":"2017","journal-title":"bioRxiv"},{"key":"10.1016\/j.medj.2021.09.002_bib86","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood-2019-131267","article-title":"Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA","volume":"134","author":"Kurtz","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.medj.2021.09.002_bib87","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/nprot.2014.170","article-title":"Detecting ultralow-frequency mutations by Duplex Sequencing","volume":"9","author":"Kennedy","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.medj.2021.09.002_bib88","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaoncol.2020.0750","article-title":"Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial","volume":"6","author":"Br\u00f6ckelmann","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib89","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/leu.2014.201","article-title":"The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing","volume":"28","author":"Liu","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.medj.2021.09.002_bib90","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2021.09.002_bib91","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.medj.2021.09.002_bib92","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.medj.2021.09.002_bib94","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.medj.2021.09.002_bib95","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.medj.2021.09.002_bib96","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.medj.2021.09.002_bib97","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2021.09.002_bib98","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.medj.2021.09.002_bib99","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.10845","article-title":"Hodgkin\u2019s lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2","volume":"103","author":"Joos","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.medj.2021.09.002_bib100","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.medj.2021.09.002_bib101","doi-asserted-by":"crossref","first-page":"14330","DOI":"10.1073\/pnas.1616440113","article-title":"Evaluating the evaluation of cancer driver genes","volume":"113","author":"Tokheim","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2021.09.002_bib102","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.medj.2021.09.002_bib103","series-title":"R: A Language and environment for statistical computing. R Foundation for Statistical Computing (Vienna, Austria)","year":"2020"},{"key":"10.1016\/j.medj.2021.09.002_bib104","series-title":"boot: Bootstrap R (S-Plus) Functions. R package version 1.3-28","author":"Canty","year":"2020"},{"issue":"D1","key":"10.1016\/j.medj.2021.09.002_bib105","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2021.09.002_bib106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"issue":"D1","key":"10.1016\/j.medj.2021.09.002_bib107","doi-asserted-by":"crossref","first-page":"D330","DOI":"10.1093\/nar\/gky1055","article-title":"The Gene Ontology Resource: 20 years and still GOing strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2021.09.002_bib108","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"10.1016\/j.medj.2021.09.002_bib109","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2021.09.002_bib111","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/JCM.37.9.2852-2857.1999","article-title":"Monitoring of epstein-barr virus DNA load in peripheral blood by quantitative competitive PCR","volume":"37","author":"Stevens","year":"1999","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.medj.2021.09.002_bib112","doi-asserted-by":"crossref","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.medj.2021.09.002_bib113","series-title":"Guidance for data quality assessment: Practical methods for data analysis","year":"2000"}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634021003172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634021003172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:55:45Z","timestamp":1763002545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634021003172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":108,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2666634021003172"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2021.09.002","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.16.21253679","asserted-by":"object"}]},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin\u2019s lymphoma and facilitates ultrasensitive residual disease detection","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}